Study of siddha drug Vaatha choornam (internal) and Vaatha mega narayana ennai (External) in the treatment of Rheumatoid arthritis(joint pain) (Valiazhal keelvayu)
Phase 3
- Conditions
- Health Condition 1: null- Vali Azhal Keel Vayu (Rheumatoid arthritis)
- Registration Number
- CTRI/2017/05/008594
- Lead Sponsor
- Ayothidoss pandithar hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
1)Age: 20- 60 years
2)Sex: Both male and female
3)Any of the following three symptoms
Pain and swelling in three or more joint
Morning Stiffness
Rheumatoid factor positive
Deformities like Swan neck and Buttton hole deformity
Rheumatoid nodules
4)Symmetrical joints involvement
5)patient willing to undergo laboratory Investigation
6)Patient willing to sign the informed consent.
Exclusion Criteria
1)Pregnancy and lactation
2)Tubercular arthritis
3)Gouty arthritis
4)Diabetic Mellitus
5) Malignant Hypertension
6)Any other systemic illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rheumatoid arthritis is diagnosed by European League against rheumatism (EULAR)and prognosis is assessed by modified health assessment questionnaire (MHAQ) <br/ ><br>Reduction of pain is assessed before and after treatment by Universal pain assessment scale using Questionnaire <br/ ><br>Improvement in restriction of movements is assessed by restricted movements assessment scaleTimepoint: 48 days
- Secondary Outcome Measures
Name Time Method 1)Safety study of drugs Muddakku vatha choornam <br/ ><br>2)Analytical study of drug muddakku vatha choornamTimepoint: 48 days